Vericel Corp. (VCEL)

[lasers]

CEO is referring to monies recognition from the warrants, conversion to shares, for this qtr and the next qtr.

The person asking the question wanted to know how much monies from ICT was recognized this Qtr for which the CC was about.




This is what Nick Colangelo said about the ICT licensing monies

Gerard will cover the specifics of the transaction, which include up to approximately $14 million through an upfront payment, equity investment and milestones as well as tiered double-digit royalty based on sales in the territory.

Nick Colangelo

We also announced this morning that the company has entered into a license agreement with Innovative Cellular Therapeutics or ICT for the development and distribution of our product portfolio in the territory of Greater China, South Korea, Singapore and select other countries in Southeast Asia. China is the second largest healthcare market in the world and ICT is a leading cell therapy company with a portfolio of CAR T cell therapies for cancer treatment.


We also announced this morning that the company has entered into a license agreement with Innovative Cellular Therapeutics or ICT for the development and distribution of our product portfolio in the territory of Greater China, South Korea, Singapore and select other countries in Southeast Asia. China is the second largest healthcare market in the world and ICT is a leading cell therapy company with a portfolio of CAR T cell therapies for cancer treatment.


Gerard will cover the specifics of the transaction, which include up to approximately $14 million through an upfront payment, equity investment and milestones as well as tiered double-digit royalty based on sales in the territory. We’re very pleased to have entered into this strategic collaboration, which allows us to begin to develop a global footprint for our product portfolio and to create another potential revenue stream for the Company.